Gene: ZNF100
Official Full Name: zinc finger protein 100provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34631 | ZNF100 Knockout cell line (HeLa) | Human | ZNF100 | 1:3~1:6 | Negative | Online Inquiry |
KO34632 | ZNF100 Knockout cell line (HCT 116) | Human | ZNF100 | 1:2~1:4 | Negative | Online Inquiry |
KO34633 | ZNF100 Knockout cell line (HEK293) | Human | ZNF100 | 1:3~1:6 | Negative | Online Inquiry |
ZNF100 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the ZNF100 gene's function and its implications in various biological processes. These cell lines are generated using CRISPR-Cas9 gene editing technology, which allows for precise disruptions in the gene of interest, creating a knockout model that enables researchers to investigate the absence of ZNF100 expression and its downstream effects.
The primary mechanism by which these knockout cell lines function involves the targeted alteration of DNA sequences within the ZNF100 locus. By leveraging the CRISPR-Cas9 system, these cell lines demonstrate a permanent loss of gene function, making them invaluable tools for elucidating the role of ZNF100 in cellular mechanisms such as transcriptional regulation, development, and disease pathology. Researchers can utilize these models to gain insights into cancer biology, neurological disorders, and other health issues where ZNF100 may play a significant role.
The scientific importance of ZNF100 Gene Knockout Cell Lines extends into both basic research and clinical applications. In academic labs, they are instrumental for functional genomics studies, aiding in the discovery of gene interactions, pathway elucidation, and potential therapeutic targets. In clinical research, understanding the ZNF100 gene's influence could lead to advances in personalized medicine, particularly in identifying biomarkers for disease prognosis and treatment efficacy.
What sets ZNF100 Gene Knockout Cell Lines apart from alternatives is their validated specificity and reliability, coupled with the ease of use provided by the CRISPR-Cas9 system. This product offers features such as high knockout efficiency and reproducibility, which significantly enhance experimental outcomes without the pitfalls commonly associated with less targeted gene disruption methods.
For researchers and clinicians, the value of ZNF100 Gene Knockout Cell Lines lies in their ability to streamline the investigation of gene functionality and potential therapeutic interventions. By utilizing these cell lines, users can accelerate their research timeline while obtaining robust and reliable data supporting their hypotheses.
Our company is committed to providing high-quality, innovative biological products that empower the scientific community. With a focus on precision and impact, we offer extensive expertise in gene editing technologies and cellular models, ensuring our clients have the best tools for their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.